Chemomab Therapeutics (CMMB) Current Leases (2019 - 2024)
Chemomab Therapeutics posted quarterly Current Leases of $115000.0 for Q4 2024, up 51.32% year-on-year from $76000.0 in Q1 2024, and up 51.32% on a QoQ basis from $76000.0 in Q4 2023.
Chemomab Therapeutics (CMMB) has 6 years of Current Leases data on file, last reported at $115000.0 in Q4 2024.
- For the quarter ending Q4 2024, Current Leases rose 51.32% year-over-year to $115000.0; the trailing twelve-month figure through Dec 2024 stood at $115000.0 (up 51.32% YoY), and the FY2024 full-year result was $115000.0, up 51.32% from the prior year.
- Current Leases for Q4 2024 stood at $115000.0, up from $76000.0 in the prior quarter.
- Across five years, Current Leases topped out at $188000.0 in Q1 2020 and bottomed at $61000.0 in Q3 2021.
- The 5-year median for Current Leases is $115000.0 (2023), against an average of $114000.0.
- The widest annual swing landed in 2020, when Current Leases plunged 82.1%; it then jumped 106.56% in 2022.
- A 5-year view of Current Leases shows it stood at $70000.0 in 2020, then jumped by 51.43% to $106000.0 in 2021, then increased by 16.04% to $123000.0 in 2022, then plunged by 38.21% to $76000.0 in 2023, then jumped by 51.32% to $115000.0 in 2024.
- The last three Current Leases figures came in at $115000.0 (Q4 2024), $76000.0 (Q4 2023), and $115000.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 115,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Mar 31, 2023 | 115,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Sep 30, 2022 | 126,000.00 |
| Jun 30, 2022 | 132,000.00 |
| Mar 31, 2022 | 116,000.00 |
| Dec 31, 2021 | 106,000.00 |
| Sep 30, 2021 | 61,000.00 |
| Jun 30, 2021 | 72,000.00 |
| Mar 31, 2021 | 69,000.00 |
| Dec 31, 2020 | 70,000.00 |
| Sep 30, 2020 | 173,000.00 |
| Jun 30, 2020 | 168,000.00 |
| Mar 31, 2020 | 188,000.00 |
| Dec 31, 2019 | 391,000.00 |
| Sep 30, 2019 | 505,000.00 |
| Jun 30, 2019 | 484,000.00 |